MedTrace Logo

Comparing Unimanual and Bimanual Mirror Therapy for Upper Limb Recovery Post Stroke

NCT02780440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2019-05-10

No results posted yet for this study

Summary

The purpose of this randomized controlled study is to

1. Examine the feasibility of a home Mirror therapy (MT) program in the NYC metropolitan area;
2. Evaluate the effectiveness of home MT versus traditional home exercise program; and
3. Evaluate the superiority of unimanual or bimanual MT intervention protocols for chronic stroke subjects with moderate hand deficits. Subjects from occupational therapy at the Ambulatory Care Center of NYU Langone Center with a diagnosis of cerebral vascular accident (CVA) or stroke will be divided into three (3) groups:

* Control Group subjects will participate in standard occupational therapy rehabilitation protocol plus a traditional home based exercise program.
* Experimental group 1 subjects will participate in standard rehabilitation protocol plus unimanual home based mirror therapy program
* Experimental group 2 subjects will participate in standard rehabilitation protocol plus bimanual home based mirror therapy program.

Conditions

  • Cerebral Vascular Accident (CVA)
  • Stroke

Interventions

BEHAVIORAL

Traditional Home Based Exercise Program

Subjects in the control group will receive a traditional home Occupational Training exercise program as per conventional OT guidelines with the same home program duration.

BEHAVIORAL

Unimanual Home Based Mirror Therapy Program

The affected hand will remain still in the mirror box, the unaffected hand will perform the exercises while the subject watches the mirror reflection.

BEHAVIORAL

Bimanual Home Based Mirror Therapy Program

The affected hand in the mirror box will best mimic the unaffected hand, while also watching the mirror reflection.

Sponsors & Collaborators

Principal Investigators

  • Steve Vanlew, MD · New York University Medical School

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02780440 on ClinicalTrials.gov